Recent highlights from GENIE v3

Highlights from Recent Cancer Literature

Recent highlights from BESIII: XYZ states

In this contribution we review recent results from the BESIII experiment. We focus on the investigation of XYZ states and the discovery of new charged charmonium like structures. Two isospin triplets Z(3900) and Z(4020) have been discovered, decaying into π±J/ψ and π±hc, respectively. Structures with compatible parameters have been found decaying to DD̄∗ and D∗D̄∗, respectively, suggesting that t...

Breaking Advances Highlights from Recent Cancer Literature

Polycomb proteins represent epigenetic regulators and exert transcriptional repression via polycomb repressive complexes (PRC). EZH2 is a component of PRC2, where it functions as a lysine methyl transferase, particularly for histones. In cancer, EZH2 is found to be overexpressed, and in glioblastoma multiforme, EZH2 has been shown to be important for maintenance of glioma stem cells (GSC). Alth...

Breaking Advances Highlights from Recent Cancer Literature

Polycomb proteins represent epigenetic regulators and exert transcriptional repression via polycomb repressive complexes (PRC). EZH2 is a component of PRC2, where it functions as a lysine methyl transferase, particularly for histones. In cancer, EZH2 is found to be overexpressed, and in glioblastoma multiforme, EZH2 has been shown to be important for maintenance of glioma stem cells (GSC). Alth...

Breaking Advances Highlights from Recent Cancer Literature

Pancreatic cancers are inherently refractory to conventional chemotherapies. Gemcitabine [20,20-difluoro-20deoxycytidine (dFdC)] is currently used as a first-line treatment against locally advanced and metastatic adenocarcinoma of the pancreas. Gemcitabine is phosphorylated intracellularly to its active diphosphate (dFdC-DP) and triphosphate (dFdC-TP) forms that inhibit DNA and RNA replication....